CLDX
NASDAQ HealthcareCelldex Therapeutics, Inc. - Common Stock
Biotechnology
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.
๐ Market Data
| Price | $41.92 |
|---|---|
| Volume | 621,390 |
| Market Cap | 3.29B |
| Beta | 0.840 |
| RSI (14-Day) | 72.9 Overbought |
| 200-Day MA | $30.46 |
| 50-Day MA | $36.57 |
| 52-Week High | $45.14 |
| 52-Week Low | $20.37 |
| Forward P/E | -10.07 |
| Price / Book | 4.61 |
๐ฏ Investment Strategy Scores
CLDX scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (86/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ช Falling Knife (8/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find CLDX in your text
Paste any article, transcript, or post โ the tool will extract CLDX and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-08-17.